Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y
Clinical trial NCT00698061 · COMPLETED
Trial details
- NCT number
- NCT00698061
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Primary completion
- 2000-09-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.